Hochschulschrift

Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Dimensions
29 cm
Extent
v, 51 Blätter
Language
Englisch
Notes
Illustrationen
Friedrich-Schiller-Universität Jena, Dissertation, 2018

Classification
Medizin, Gesundheit

Event
Veröffentlichung
(where)
Jena
(when)
[2018?]
Creator

Table of contents
Rights
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
Last update
11.06.2025, 2:27 PM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Object type

  • Hochschulschrift

Associated

Time of origin

  • [2018?]

Other Objects (12)

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification

Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms

Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms

Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms

Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5

Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5

Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis

Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis

Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm

Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm

Related objects